Edwin Tucker
Chief Tech/Sci/R&D Officer chez JASPER THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Profil
Edwin J.
Tucker currently works at The Royal College of Physicians, as Member and Jasper Therapeutics, Inc., as Chief Medical Officer from 2023.
Dr. Tucker also formerly worked at Genentech, Inc., as Vice President-Global Safety from 2013 to 2015, Johnson & Johnson, as Vice President-Global Safety from 2010 to 2013, Goldfinch Bio, Inc., as Chief Medical Officer, Mirum Pharmaceuticals, Inc., as Chief Medical Officer from 2019 to 2021, and Acerta Pharma LLC, as Chief Operating Officer from 2018 to 2019.
Dr. Tucker received his doctorate degree from the University of Leeds and Masters Business Admin degree from the University of Connecticut.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Edwin Tucker
| Sociétés | Poste | Début |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 12/06/2023 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
Anciens postes connus de Edwin Tucker
| Sociétés | Poste | Fin |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/11/2021 |
| Acerta Pharma LLC | Compliance Officer | 01/01/2018 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2015 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2013 |
Goldfinch Bio, Inc.
 Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
Formation de Edwin Tucker
| University of Leeds | Doctorate Degree |
| University of Connecticut | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| MIRUM PHARMACEUTICALS, INC. | Health Technology |
| JASPER THERAPEUTICS, INC. | Finance |
| Entreprise privées | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Health Technology |
| Acerta Pharma LLC |
